Results 151 to 160 of about 153,974 (268)

Examining stressful life experiences as risk factors for self‐injurious behaviors as a function of sexual minority status in adults

Journal of Traumatic Stress, EarlyView.
Abstract Self‐injurious behaviors (SIBs) represent a major public health concern in the United States. Although sexual minority individuals experience disproportionately high rates of SIBs, research identifying population‐specific risk factors remains limited. This study examined how stressful experiences common among sexual minority (SM) adults relate
Samantha M. Haas, Naomi Sadeh
wiley   +1 more source

Chess in Mental Health: Therapeutic Potential and Neurocognitive Mechanisms—A Systematic Review

Medicine Bulletin, EarlyView.
ABSTRACT Objective Chess is an ancient game with simple rules but high cognitive demands. This review examined chess as a cognitive tool for patients with mental disorders and explored the cognitive mechanisms and neural structures that may underlie its effects. Method A systematic review of studies was conducted following PRISMA guidelines.
Maria Rodrigo‐Yanguas, Fernand Gobet, Marcos Bella‐Fernández, Marina Martin‐Moratinos, Hilario Blasco‐Fontecilla   +4 more
wiley   +1 more source

Epidemiological Signals, Knowledge Gaps, and Practice Considerations From the 2024 Functional Neurological Disorder Society International Meeting: A Conference Report With Narrative Synthesis

Medicine Bulletin, EarlyView.
ABSTRACT The 2024 International Conference on Functional Neurological Disorders brought together clinicians, researchers, advocates, and service‐user representatives to discuss recent developments in functional neurological disorder and related functional disorders.
Yadira Velazquez‐Rodriquez, Jennifer Brown, Katherine Gill   +2 more
wiley   +1 more source

Methylphenidate Treatment and Risk of Psychotic Disorder.

JAMA Psychiatry
Healy C, O'Hare K, Lång U, Metsälä J, Pulakka A, McGrath J, Migone M, Keating D, Romaniuk L, Gyllenberg D, Kajantie E, Perrett G, Hill J, Elwert F, Kelleher I.   +14 more
europepmc   +1 more source

"I think there is a certain worm that disturbs the head": Community perspectives and care pathways for psychosis in Malawi. [PDF]

PLOS Ment Health
Chasweka D, Chidzalo K, Sibande W, Kokota D, Udedi M, Pickersgill M, Hanlon C, Lawrie SM, Manda-Taylor L, Jain S.   +9 more
europepmc   +1 more source

Movement Disorders Associated with 22q11.2 Microdeletion: A Scoping Review

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Movement disorders have recently emerged as important neurologic manifestations of the 22q11.2 microdeletion that affects nearly one in every 2000 live births. Objective We aimed to map the existing evidence regarding the spectrum, diagnosis and treatment, and etiopathogenesis of movement disorders associated with 22q11.2 ...
Nikolai Gil D. Reyes, Daniel G. Di Luca, Connie Marras, Erik Boot, Ryan K.C. Yuen, Anthony E. Lang, Anne S. Bassett   +6 more
wiley   +1 more source

Interventions in schizophrenia should be transdiagnostic, biologically informed, individualized, and disease modifying. [PDF]

World Psychiatry
Keshavan MS.
europepmc   +1 more source

Considerations for Initiation and Maintenance of Foslevodopa/Foscarbidopa for Advanced Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background As Parkinson's disease (PD) progresses, motor fluctuations become increasingly difficult to manage with oral medications. Foslevodopa/foscarbidopa (LDp/CDp), delivered as a continuous 24‐h/day subcutaneous infusion, offers continuous levodopa delivery and stable plasma levodopa levels that reduce motor fluctuations. LDp/CDp has been
K. Ray Chaudhuri, Bruno Bergmans, Eric Freire‐Alvarez, Lucie Hopes, Drew S. Kern, Robert S. Kirsner, Giulia Lazzeri, Pedro Mendes‐Bastos, Noriko Nishikawa, Per Odin, Karolina Poplawska‐Domaszewicz, Rajesh Pahwa, Yuval Ramot, Klaus Seppi, Tobias Warnecke, Robert Wiggins, Megha B. Shah, Pavnit Kukreja, Bjoern Fritz, Koray Onuk, Stuart H. Isaacson   +20 more
wiley   +1 more source

The Utility of Addenbrooke's Cognitive Examination III (ACE-III) in Differentiating Neurodegenerative Disorders with Psychotic Symptoms: A Narrative Review. [PDF]

Healthcare (Basel)
Barczak A.
europepmc   +1 more source

Continuous Subcutaneous Versus Intestinal Levodopa Infusion for Parkinson's Disease: A Real‐World, Monocentric, Observational Study and Critical Review

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Subcutaneous foslevodopa‐foscarbidopa (SCFF) is a novel, non‐surgical dopaminergic infusion therapy for better controlling motor fluctuations in advanced Parkinson's disease (PD). However, there are scarce real‐world data on efficacy, adverse events and comparisons with other infusion strategies. Objectives Here, we aimed to provide
Johannes Hartig, Lennert Sitzmann, Doreen Hartenstein, Marion Labisch, Chi Wang Ip, Jens Volkmann, Christine Daniels   +6 more
wiley   +1 more source